Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Synairgen Share Price
  4. Synairgen Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksSynairgen Share News (SNG)

Synairgen Information

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 5.52
Ask: 7.00
Change: 0.08 (1.31%)
Spread: 1.48 (26.812%)
Open: 6.20
High: 6.20
Low: 6.20
Prev. Close: 6.12
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 23rd Sep 2021 15:59

Friday 24 September 
Carnival PLCQ3 Results
Dunedin Enterprise Investment Trust PLCHalf Year Results
Judges Scientific PLCHalf Year Results
Monday 27 September 
Beeks Financial Cloud Group PLCFull Year Results
FireAngel Safety Technology GroupHalf Year Results
i3 Energy PLCHalf Year Results
Instem PLCHalf Year Results
Medica Group PLCHalf Year Results
Microsaic Systems PLCHalf Year Results
Minds + Machines Group LtdHalf Year Results
Oxford Cannabinoid Technologies Holdings PLCFull Year Results
United Utilities Group PLCTrading Statement
Tuesday 28 September 
AG Barr PLCHalf Year Results
Animalcare Group PLCHalf Year Results
Blancco Technology Group PLCFull Year Results
Brand Architekts Group PLCFull Year Results
Card Factory PLCHalf Year Results
Close Brothers Group PLCFull Year Results
Digitalbox PLCHalf Year Results
Ergomed PLCHalf Year Results
Escape Hunt PLCHalf Year Results
Ferguson PLCFull Year Results
HeiQ PLCHalf Year Results
Hotel Chocolat Group PLCFull Year Results
Immotion Group PLCHalf Year Results
Itaconix PLCHalf Year Results
Lords Group Trading PLCHalf Year Results
Moonpig Group PLCTrading Statement
Mortgage Advice Bureau Holdings PLCHalf Year Results
Next Fifteen Communications Group PLCHalf Year Results
Northcoders Group PLCHalf Year Results
Pennon Group PLCTrading Statement
S&U plcHalf Year Results
Serica Energy PLCHalf Year Results
Smiths Group PLCFull Year Results
SourceBio International PLCHalf Year Results
Transense Technologies PLCFull Year Results
Yourgene Health PLCTrading Statement
Wednesday 29 September 
1Spatial PLCHalf Year Results
Allied Minds PLCHalf Year Results
Cap-XX LtdFull Year Results
CMO Group PLCHalf Year Results
Futura Medical PLCHalf Year Results
Glantus Holdings PLCHalf Year Results
MyCelx Technologies CorpHalf Year Results
MyHealthChecked PLCHalf Year Results
NetScientific PLCHalf Year Results
Next PLCHalf Year Results
Origin Enterprises PLCFull Year Results
Quiz PLCFull Year Results
SEEEN PLCHalf Year Results
SSE PLCTrading Statement
SSP Group PLCTrading Statement
Sumo Group PLCHalf Year Results
Yu Group PLCHalf Year Results
Thursday 30 September 
Angle PLCHalf Year Results
Avacta Group PLCHalf Year Results
Boohoo Group PLCHalf Year Results
Ceres Power Holdings PLCHalf Year Results
Go-Ahead Group PLCFull Year Results
Physiomics PLCFull Year Results
Power Metal Resources PLCTrading Statement
Renishaw PLCFull Year Results
Rockhopper Exploration PLCHalf Year Results
Synairgen PLCHalf Year Results
WANdisco PLCHalf Year Results
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 Jan 2021 21:16

IN BRIEF: Synairgen Recruits Covid-19 Patients Into Phase II Trial

IN BRIEF: Synairgen Recruits Covid-19 Patients Into Phase II Trial

Read more
13 Jan 2021 10:24

Synairgen Doses First Patient In Covid-19 Treatment Trial

Synairgen Doses First Patient In Covid-19 Treatment Trial

Read more
11 Jan 2021 20:54

COVID SCIENCE-COVID-19 patients still have symptoms 6 months later; interferon may be helpful treatment after all

By Nancy LapidJan 11 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.Half a year later, COVID-19 pat...

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 11:06

Synairgen Gets Fast Track Designation From US FDA For Covid-19 Vaccine

Synairgen Gets Fast Track Designation From US FDA For Covid-19 Vaccine

Read more
18 Dec 2020 10:29

Synairgen makes solid progress with Covid-19 treatment

(Sharecast News) - Respiratory drug development company Synairgen updated the market on its phase 3 trial design evaluating SNG001 as a treatment for patients with Covid-19 on Friday, as well as positive progress on its regulatory path.

Read more
18 Nov 2020 13:59

finnCap Interim Profit More Than Doubles; Chair To Step Down

finnCap Interim Profit More Than Doubles; Chair To Step Down

Read more
13 Nov 2020 14:28

Synairgen surges on positive results for Covid-19 treatment

(Sharecast News) - Synairgen shares surged on Friday after data from trials of its inhaled Covid-19 treatment, SNG001, published in The Lancet Respiratory Medicine, showed positive results in hospitalised patients.

Read more
13 Nov 2020 10:24

Synairgen Drug Helps Recovery In Hospitalised Covid-19 Patients

Synairgen Drug Helps Recovery In Hospitalised Covid-19 Patients

Read more
2 Nov 2020 20:03

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

Read more
15 Oct 2020 11:39

Synairgen Raises GBP80 Million In Placing, To Launch Open Offer

Synairgen Raises GBP80 Million In Placing, To Launch Open Offer

Read more
14 Oct 2020 18:02

IN BRIEF: Synairgen Looks To Raise GBP80 Million For SNG001 Trial

IN BRIEF: Synairgen Looks To Raise GBP80 Million For SNG001 Trial

Read more
29 Sep 2020 12:14

Synairgen Progresses Covid-19 Treatment As Expenses Increase

Synairgen Progresses Covid-19 Treatment As Expenses Increase

Read more
9 Sep 2020 16:04

IN BRIEF: Synairgen Makes Inhaled Interferon Beta Patent Application

IN BRIEF: Synairgen Makes Inhaled Interferon Beta Patent Application

Read more
9 Sep 2020 12:23

Synairgen files for another patent on 'SNG001'

(Sharecast News) - Respiratory drug development company Synairgen updated the market on its intellectual property for the wholly-owned inhaled interferon beta asset 'SNG001' on Wednesday.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.